Radiopharm Theranostics increases stake in cancer drug joint venture to 87.5% Jan 12, 2026 07:03AM
Radiopharm reports 92% success rate in brain cancer imaging trial Dec 15, 2025 07:02AM
Radiopharm Theranostics (RADX) PT Lowered to $13 at B.Riley Nov 26, 2025 09:11AM
Radiopharm Theranostics reports clinical progress on four drug programs Oct 20, 2025 08:05AM
Radiopharm Theranostics raises A$35 million in institutional placement, launches share buyback Oct 20, 2025 07:31AM


Jul 28, 2025 08:02AM Radiopharm receives FDA approval to start phase I trial for RV-01
Jul 22, 2025 09:04AM Radiopharm Theranostics adds cancer specialist to scientific advisory board
Jul 21, 2025 07:25AM Brookline Capital Markets Starts Radiopharm Theranostics (RADX) at Buy
Jun 24, 2025 08:01AM Radiopharm Theranostics (RADX) and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
May 12, 2025 06:14AM ThinkEquity Starts Radiopharm Theranostics (RADX) at Buy
Mar 12, 2025 03:32AM B.Riley Starts Radiopharm Theranostics (RADX) at Buy
Nov 27, 2024 08:01AM Radiopharm (RADX) Achieves Nasdaq Listing of American Depositary Shares